The results of an in vitro study have revealed that Innophos' magnesium ingredients can be effectively absorbed by cells.
Tests were performed on the company's Chelamax range, which includes magnesium bisglycinate and magnesium citrate.
Results of the study are detailed in a whitepaper, which can be found on Innophos' website.
In the whitepaper, Innophos delves into a range of aspects, including:
- Why magnesium supplements, and why is there a growing demand for this functional ingredient?
- Why bioavailability is an important factor
- Why bisglycinate and citrate forms are better than magnesium oxide
- Comparisons between Chelamax and other leading magnesium brands
Chelamax's better bioavailability
During the in vitro study, it was found that Chelamax magnesium bisglycinate had an absorption of 64%, while the company's magnesium citrate stood at a 47% absorption rate.
These figures were significantly higher than the absorption rate of magnesium oxide, which only reached an absorption rate of 8%.
Additionally, when Innophos' magnesium bisglycinate solution was compared to leading mineral provider Albion's magnesium bisglycinate, it was found to be 17% more bioavailable.
VP of Innovation at Innophos, Karen Winkowski, commented: “This whitepaper presents scientific evidence from our latest in vitro study, showing that Chelamax chelated magnesium delivers superior absorption in the gastrointestinal tract compared to magnesium oxide and a leading competitor’s product,”
“With our broad range of magnesium products, manufacturers can formulate supplements with improved bioavailability in capsules, tablets or gummies.”
Innophos offers a range of magnesium forms for different applications, while also providing customers with technical and formulation support.